KPC Pharmaceuticals Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares KPC Pharmaceuticals Inc with three other
companies in this sector in China:
Zhejiang Conba Pharmaceutical Co., Ltd.
sales of 5.30 billion Chinese Renmimbi [US$768.17 million]
of which 70%
Dong-E-E-Jiao Co Ltd
(5.45 billion Chinese Renmimbi [US$789.33 million]
of which 88%
was Medicine Manufacturing), and
Zhejiang Medicine Co., Ltd.
(4.50 billion Chinese Renmimbi [US$651.42 million]
of which 41%
KPC Pharmaceuticals Inc reported sales of 4.92 billion Chinese Renmimbi (US$712.27 million)
December of 2015.
increase of 19.3%
versus 2014, when the company's sales were 4.12 billion Chinese Renmimbi.
Sales at KPC Pharmaceuticals Inc have increased during each of the previous five years
(and since 2010, sales have increased a total of 170%).
Sales of Other Operating saw an increase
that was more than double the company's growth rate: sales were up
154.9% in 2015, from
27.27 million Chinese Renmimbi to 69.51 million Chinese Renmimbi.